Oncotelic Therapeutics (OTLC) Stock Chart & Stock Price History $0.05 -0.01 (-12.41%) As of 03:53 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Oncotelic Therapeutics Stock Price Performance The Oncotelic Therapeutics (OTLC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 25.70%, with a year-to-date return of 41.14%. In the past month, the stock has decreased 15.84%, reflecting recent market activity. As of the latest close, Oncotelic Therapeutics traded at $0.06 with a market cap of $23.03 million and volume of 95,692 shares. Receive OTLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-20.96%1 Month Performance-15.84%3 Month Performance-6.79%Year-To-Date Performance+41.14%1 Year Performance+25.70% OTLC Stock Chart for Friday, June, 13, 2025 OTLC Chart by TradingView Oncotelic Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$0.06$0.06$0.06$0.0695,692 shs$23.03 million06/11/2025$0.05$0.06+11.68%$0.06$0.0615,525 shs$23.03 million06/10/2025$0.06$0.05-20.35%$0.06$0.05144,588 shs$20.62 million06/09/2025$0.06$0.06+1.44%$0.07$0.0638,024 shs$25.89 million06/06/2025$0.06$0.06+5.40%$0.06$0.065,100 shs$25.52 million06/05/2025$0.06$0.06-2.47%$0.06$0.067,500 shs$24.21 million06/04/2025$0.06$0.06-1.94%$0.06$0.062,001 shs$24.82 million06/03/2025$0.06$0.06-2.36%$0.06$0.064,806 shs$25.31 million06/02/2025$0.07$0.06-2.31%$0.07$0.0621,585 shs$25.93 million05/30/2025$0.07$0.07$0.07$0.072,000 shs$26.54 million Get the Latest News and Ratings for OTLC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$0.06$0.07+3.17%$0.07$0.072,051 shs$26.54 million05/28/2025$0.06$0.06+5.00%$0.07$0.0637,516 shs$25.72 million05/27/2025$0.07$0.06-7.69%$0.07$0.0647,865 shs$24.50 million05/26/2025$0.07$0.07$0.07$0.0651,500 shs$26.54 million05/23/2025$0.06$0.07+5.18%$0.07$0.0651,500 shs$26.54 million05/22/2025$0.06$0.06-0.32%$0.07$0.0624,678 shs$25.23 million05/21/2025$0.06$0.06+3.33%$0.06$0.06273 shs$25.31 million05/20/2025$0.06$0.06+5.08%$0.06$0.0541,894 shs$24.50 million05/19/2025$0.05$0.06+9.60%$0.06$0.0513,431 shs$23.31 million05/16/2025$0.06$0.05-5.44%$0.06$0.0532,938 shs$21.27 million05/15/2025$0.06$0.06-3.16%$0.06$0.0515,245 shs$22.50 million05/14/2025$0.06$0.06-3.07%$0.06$0.0512,500 shs$23.23 million05/13/2025$0.06$0.06$0.06$0.0542,000 shs$23.97 million05/12/2025$0.06$0.06$0.06$0.063,193 shs$23.97 million Related Companies XBIT Stock Price Chart PDSB Stock Price Chart FBRX Stock Price Chart IMUX Stock Price Chart OCX Stock Price Chart PYXS Stock Price Chart EPIX Stock Price Chart CLLS Stock Price Chart ELUT Stock Price Chart SKYE Stock Price Chart Receive OTLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:OTLC) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncotelic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncotelic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
